iShares Core S&P 500 ETF vs Altria Group Inc — how do they compare? iShares Core S&P 500 ETF trades at $752.12, while Altria Group Inc trades at $72.99 (market cap $124.67B). The key difference: Altria Group Inc pays a 5.68% dividend while iShares Core S&P 500 ETF pays none. Which is the better fit depends on your goals.
| IVV | MO | |
|---|---|---|
Sector | Broad Market / Factor | Consumer Staples |
52-Week High | $763.10 | $74.66 |
52-Week Low | $624.65 | $54.72 |
Market Cap | — | $124.67B |
Enterprise Value | — | $145.75B |
Dividend Yield | — | 5.68% |
Signals from Pluang's Aura AI — not financial advice
IVV, tracking the S&P 500, trades at $745.67, down 0.14% with a bearish technical signal from moving averages. The fund remains heavily weighted toward technology stocks, with recent news highlighting concentration risks and debates over valuation. A dividend of $2.00 is scheduled for June 2026, providing income amid market volatility.
Outlook is cautious due to technical weakness and high tech exposure, though long-term growth prospects from AI and earnings strength offer potential. Key risks include market concentration, valuation concerns, and macroeconomic shifts impacting broad index performance.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
IVV tracks the performance of the S&P 500 Index, offering low-cost exposure to 500 of the largest US companies. It is a cornerstone for long-term investors seeking broad growth in the US stock market.
Read more on IVV →Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).
Read more on MO →